Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103073496A reveals a streamlined N-methylation route for Dextromethorphan, eliminating genotoxic impurities and reducing manufacturing costs for API intermediates.
Patent CN106866630B reveals high-yield asymmetric oxidation for R-lansoprazole. Reduces impurities and enhances commercial scalability for pharmaceutical supply chains globally.
Novel selective synthesis method for diltiazem intermediate improves yield and purity. Cost-effective supply chain solution for pharmaceutical manufacturing partners globally.
Patent CN115109109A details a greener synthesis of acetamido abamectin using TBS protection and integrated acetylation, offering significant cost reduction and supply chain reliability for manufacturers.
Novel benzyne-mediated route for benzo[c]carbazole-5-carboxamides offers high efficiency and supply chain stability for antitumor drug development.
Advanced resolution and racemization process for L-synephrine intermediates. Reduces waste and improves supply chain reliability for pharmaceutical manufacturing.
Novel intramolecular Heck reaction synthesis offers superior anti-fibrosis activity. Streamlined process ensures cost reduction and supply chain reliability for global pharmaceutical intermediates manufacturing partners.
Novel transaminase mutants for chiral amine production. Enhanced stability at 55°C and pH 10. Cost-effective biocatalysis for pharma intermediates.
Patent CN111484528A reveals a novel halogenation route for TAF intermediates, offering superior purity and cost efficiency for pharmaceutical manufacturing supply chains.
Novel patent CN103772384A details a low-cost Tadalafil route using L-tryptophan. Achieves >99.5% purity without expensive D-tryptophan. Ideal for generic API manufacturing.
Novel CN108264529A route for Tildipirosin reduces steps and waste. Ideal for reliable veterinary drug supplier seeking cost reduction in macrolide manufacturing.
Patent CN114409609B details high-yield synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN101481665B reveals a green biocatalytic route for 2,2-dimethylcyclopropanecarboxamide, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel radical substitution method for ortho-trifluoromethyl aniline derivatives offers noble-metal-free production and enhanced supply chain reliability for global pharmaceutical intermediate manufacturing.
Patent CN121045046A reveals safe SF6 activation for SF5-BCP derivatives. Enables cost reduction in pharmaceutical intermediates manufacturing with green chemistry.
Patent CN1041785A details enzymatic resolution for high-purity chiral esters. This report analyzes supply chain stability and cost reduction in API intermediate manufacturing.
Patent CN113801027A reveals a high-yield synthesis route for dapoxetine hydrochloride offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Patent CN113825764B reveals chromatography-free synthesis reducing impurities significantly for scalable pharmaceutical intermediate manufacturing and supply chain reliability.
Patent CN112912390A reveals a convergent solid-phase method for Liraglutide and Semaglutide using pseudoproline fragments to ensure high yield and purity for pharmaceutical manufacturing.
Patent CN107488176B details a cost-effective route for Famciclovir Impurity C using alpha-methyl-gamma-butyrolactone, ensuring high purity for quality control.